HUP0002742A2 - Mirtazapint és antipszichotikus szert tartalmazó új gyógyászati kombinációk pszichózisos rendellenességek kezelésére vagy megelőzésére - Google Patents

Mirtazapint és antipszichotikus szert tartalmazó új gyógyászati kombinációk pszichózisos rendellenességek kezelésére vagy megelőzésére

Info

Publication number
HUP0002742A2
HUP0002742A2 HU0002742A HUP0002742A HUP0002742A2 HU P0002742 A2 HUP0002742 A2 HU P0002742A2 HU 0002742 A HU0002742 A HU 0002742A HU P0002742 A HUP0002742 A HU P0002742A HU P0002742 A2 HUP0002742 A2 HU P0002742A2
Authority
HU
Hungary
Prior art keywords
mirtazapine
treatment
prophylaxis
psychotic disorders
antipsychotic agents
Prior art date
Application number
HU0002742A
Other languages
English (en)
Inventor
Hermanus Henricus Gerardus Berendsen
Christophorus Louis Eduard Broekkamp
Roger Martin Pinder
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUP0002742A2 publication Critical patent/HUP0002742A2/hu
Publication of HUP0002742A3 publication Critical patent/HUP0002742A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A jelen találmány tárgyát mirtazapint és antipszichotikus szerttartalmazó új gyógyászati kombinációk és ezen kombinációkat tartalmazógyógyászati készítmények képezik, amelyek pszichotikusrendellenességek kezelésében vagy megelőzésében alkalmazhatók, továbbáa találmányhoz tartoznak a fentieket tartalmazó páciens csomagok". Ó
HU0002742A 1997-03-27 1998-03-25 New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders HUP0002742A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97200881 1997-03-27
EP97202785 1997-09-11
PCT/EP1998/001920 WO1998043646A1 (en) 1997-03-27 1998-03-25 New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders

Publications (2)

Publication Number Publication Date
HUP0002742A2 true HUP0002742A2 (hu) 2001-05-28
HUP0002742A3 HUP0002742A3 (en) 2003-03-28

Family

ID=26146283

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002742A HUP0002742A3 (en) 1997-03-27 1998-03-25 New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders

Country Status (25)

Country Link
EP (1) EP0969845B1 (hu)
JP (2) JP4377456B2 (hu)
KR (1) KR100577865B1 (hu)
CN (1) CN1226036C (hu)
AR (1) AR012193A1 (hu)
AT (1) ATE318604T1 (hu)
AU (1) AU726194B2 (hu)
BR (1) BR9808077A (hu)
CA (1) CA2284551C (hu)
CZ (1) CZ298105B6 (hu)
DE (1) DE69833645T2 (hu)
DK (1) DK0969845T3 (hu)
ES (1) ES2259207T3 (hu)
HK (1) HK1023293A1 (hu)
HU (1) HUP0002742A3 (hu)
ID (1) ID22283A (hu)
IL (1) IL123716A (hu)
NO (1) NO994673L (hu)
NZ (1) NZ337618A (hu)
PL (1) PL191449B1 (hu)
PT (1) PT969845E (hu)
RU (1) RU2222330C2 (hu)
TR (1) TR199902334T2 (hu)
TW (1) TW587938B (hu)
WO (1) WO1998043646A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6280763B1 (en) 1999-05-10 2001-08-28 Pierce Management, Llc Apparatus and method for transdermal delivery of bupropion
FR2797399B1 (fr) * 1999-08-13 2002-10-18 Aventis Pharma Sa Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines
US6350773B1 (en) 1999-12-10 2002-02-26 American Home Products Corporation Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
FR2802101B1 (fr) * 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
RU2268725C2 (ru) * 2000-01-19 2006-01-27 Акцо Нобель Н.В. Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
EP1795199A3 (en) * 2001-02-06 2007-07-25 AstraZeneca AB Quetiapine for the treatment of substance dependence or substance abuse
EP1359919B1 (en) * 2001-02-06 2007-04-25 AstraZeneca AB Use of quetiapine for the treatment of cocaine dependence
TW200517106A (en) 2003-10-29 2005-06-01 Wyeth Corp Sustained release pharmaceutical compositions
EP1547650A1 (en) * 2003-12-02 2005-06-29 B & B Beheer NV Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
PT1541197E (pt) * 2003-12-02 2009-06-04 Pharmaneuroboost N V Utilização de pipamperona e de um sndri, snri ou ssri para o tratamento de patologias do temperamento ou da ansiedade
US7884096B2 (en) 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
CA2547639A1 (en) * 2003-12-02 2005-06-16 B&B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
US7855195B2 (en) 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
AU2005249206A1 (en) 2004-06-03 2005-12-15 F. Hoffmann-La Roche Ag Treatment with cisplatin and an EGFR-inhibitor
MX2008015794A (es) * 2006-06-09 2009-01-12 Dainippon Sumitomo Pharma Co Preparacion de cinta novedosa.
AR085840A1 (es) * 2011-04-05 2013-10-30 Otsuka Pharma Co Ltd Medicamento que contiene un compuesto que es 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoxi]-1h-quinolin-2-ona
DE102012011839B4 (de) 2012-06-14 2018-03-22 Norbert Müller Verwendung von Interferon-gamma in einem Verfahren zur Behandlung von psychiatrischen Erkrankungen
RU2509560C1 (ru) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые терапевтические комбинации миртазапина для применения при болевых расстройствах

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
ES2062310T3 (es) * 1989-12-06 1994-12-16 Akzo Nv Un procedimiento para fabricar un preparado farmaceutico acuoso estabilizado.
ZA935078B (en) * 1992-07-15 1994-02-07 Nicolaas Johannes Jaco Loetter Pharmaceutical composition
DK0669128T3 (da) * 1992-11-17 2000-06-19 Yoshitomi Pharmaceutical Sustained-release mikrosfære indeholdende antipsykotikum og fremgangsmåde til at fremstille samme
JPH07242669A (ja) * 1994-03-07 1995-09-19 Akikazu Ogawa 四環系とブチロフェノン誘導体を化学結合した化合物

Also Published As

Publication number Publication date
EP0969845B1 (en) 2006-03-01
JP4377456B2 (ja) 2009-12-02
CA2284551C (en) 2007-06-12
BR9808077A (pt) 2000-03-08
CA2284551A1 (en) 1998-10-08
AU7213998A (en) 1998-10-22
ATE318604T1 (de) 2006-03-15
ES2259207T3 (es) 2006-09-16
TW587938B (en) 2004-05-21
HK1023293A1 (en) 2000-09-08
IL123716A (en) 2001-03-19
KR100577865B1 (ko) 2006-05-10
CN1226036C (zh) 2005-11-09
JP5023315B2 (ja) 2012-09-12
AR012193A1 (es) 2000-09-27
NZ337618A (en) 2000-06-23
NO994673D0 (no) 1999-09-24
JP2009280596A (ja) 2009-12-03
TR199902334T2 (xx) 2000-01-21
KR20010005677A (ko) 2001-01-15
DE69833645D1 (de) 2006-04-27
DK0969845T3 (da) 2006-06-19
AU726194B2 (en) 2000-11-02
WO1998043646A1 (en) 1998-10-08
CZ298105B6 (cs) 2007-06-27
PL335890A1 (en) 2000-05-22
EP0969845A1 (en) 2000-01-12
CN1251526A (zh) 2000-04-26
PT969845E (pt) 2006-05-31
JP2001521497A (ja) 2001-11-06
RU2222330C2 (ru) 2004-01-27
CZ343199A3 (cs) 2000-04-12
ID22283A (id) 1999-09-30
DE69833645T2 (de) 2006-08-24
IL123716A0 (en) 1998-12-06
HUP0002742A3 (en) 2003-03-28
NO994673L (no) 1999-11-17
PL191449B1 (pl) 2006-05-31

Similar Documents

Publication Publication Date Title
HUP0002742A2 (hu) Mirtazapint és antipszichotikus szert tartalmazó új gyógyászati kombinációk pszichózisos rendellenességek kezelésére vagy megelőzésére
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
HK1056683A1 (en) New pharmaceutical composition
GB2373726B (en) Pharmaceutical formulations containing zolmitriptan
BR9711259A (pt) Droga preventiva ou terapeutica para doen-a de alzheimer
HK1029937A1 (en) Use of phanquinone for the treatment of alzheimer s disease.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
HUP0002836A2 (hu) Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
AU8015398A (en) Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
HUP0203309A2 (hu) (S)-2-(benzilamino-metil)-2,3,8,9-tetrahidro-7H-1,4-dioxino[2,3-e]indol-8-on és neuroleptikumok terápiás kombinációi pszichotikus rendellenességek kezelésére vagy megelőzésére és ezeket tartalmazó gyógyszerkészítmények
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
TR200000916T2 (tr) İkameli piperidin türevleri.
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: N.V. ORGANON, NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished